Short Interest Update on Lannett Co Inc (LCI)

Lannett Co Inc (LCI) : The short interest in Lannett Co Inc (LCI) has changed with an increase of 685,515 shares and the open interest is 10.1%. From 6,765,042 short positions on Jul 29, 2016, the shorts increased to 7,450,557 shares by August 15, 2016. There are 14 more days left for the expiry and the daily trading volume of the stock is 536,426 shares. The total interest of shorts is 25.4% of the shares available to the public. The short interest information was released on Wednesday Aug 24th after the market close.

Lannett Co Inc (NYSE:LCI): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $37.49 and $35.07 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $39.99. The buying momentum continued till the end and the stock did not give up its gains. It closed at $36.75, notching a gain of 13.71% for the day. The total traded volume was 7,241,241 . The stock had closed at $32.32 on the previous day.


In a related news, Dedhiya Mahendra, officer (Chief Scientific Affairs) of Lannett Co Inc, executed a transaction worth $24,840 on February 5, 2016. A total of 1,000 shares were purchased at an average price of $24.84. The Insider information was divulged by the Securities and Exchange Commission in a Form 4 filing. The information is based on open market trades at the market prices.Option exercises are not covered.

Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Companys products include Levothyroxine Sodium tablets, Digoxin tablets, Butalbital products, Ursodiol capsules and pain management products. Levothyroxine Sodium tablets are produced and marketed with around 12 varying potencies. Digoxin tablets are produced and marketed with approximately two different potencies. It distributes around three products containing Butalbital. Ursodiol capsules are produced and marketed in 300 milligram capsules. The Company offers a range of pain management products, such as Cocaine Topical Solution (C-Topical), Morphine Sulfate Oral Solution, Hydromorphone hydrochloric acid (HCl) tablets and Codeine Sulfate tablets.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.